Key Takeaway: Acadia Pharmaceuticals Inc. has announced its participation in the Canaccord Genuity 46th Annual Growth Conference. The event is scheduled for August 12, 2026, at 1:30 p.m. Eastern Time. Investors can access live webcasts on the company's website, with recordings available for a month post-event.
Price reaction · baseline $26.55 (2026-07-30 close) · hit after-hours · clean, no other ACAD news in the window
day 0 close · peak
-2.6%
Market Sentiment Analysis
POSITIVE FACTORS
Acadia Pharmaceuticals is actively engaging with investors.
Participation in a reputable conference highlights company visibility.
Live webcasts provide transparency and accessibility for stakeholders.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
4.5%
average across 10 past catalysts
Lead asset
ACP-211
Phase 2 · Major Depressive Disorder (MDD)
Full Press Release Details
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 1:30 p.m. Eastern Time. Live webcasts will be accessible on the company’s website, acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation. About Acadia Pharmaceuticals Acadia is commit
Frequently Asked Questions
When will Acadia participate in the conference?
Acadia will participate on August 12, 2026, at 1:30 p.m. Eastern Time.
Where can I watch the live webcast?
The live webcasts will be available on Acadia's website under the investors section.
How long will the archived recording be available?
The archived recording will be accessible for approximately one month after the presentation.